What top creators are saying about Schrödinger, Inc.(SDGR)

Software company providing computational chemistry and drug discovery solutions.

5 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 3 scored insights about Schrödinger, Inc..

Bearish
avg -0.30
0 bullish1 neutral2 bearish
Investment Summary
Updated 10 days ago
Summary of insights about Schrödinger, Inc. in the last 30 days

The Take

Recent coverage leans bearish: all three insights express skepticism about Schrödinger (SDGR), though they acknowledge its software business may have value. The central concern is whether its established software is sufficiently differentiated, especially given open-source alternatives.

Bull Case

  • Software business: The speakers acknowledged Schrödinger has a software business that could still be a good business. (The Shkreli Pill, Martin Shkreli)

Bear Case

  • Differentiation concerns: One speaker questioned how unique Schrödinger’s established software is and noted that similar software can be open source. (The Shkreli Pill)
  • Lack of bullish conviction: Martin Shkreli said he had never been bullish on the company and reiterated that he was not bullish. (The Shkreli Pill, Martin Shkreli)

AI-generated summary. Not investment advice. Learn more.

Top creators covering Schrödinger, Inc. (SDGR)

The 3 sources with the most insights about Schrödinger, Inc. on Kazuha.

Latest insights about Schrödinger, Inc. (SDGR)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Wednesday, November 11, 2026

Neutral

The speaker questioned how unique its established software is, noting similar software can be open source, but allowed that it could still be a good business.

Tuesday, November 10, 2026

Bearish

The speaker said he had never been bullish on the company, while acknowledging its software business.

Monday, November 9, 2026

Bearish

The host said he was not bullish on Schrödinger, while acknowledging its software business.

Sunday, October 11, 2026

Neutral

A relevant public-market peer in AI drug discovery, but the transcript provides no company-specific financial, partnership, or clinical details to support a directional conclusion.

Wednesday, October 7, 2026

Neutral

The ticker appeared in the episode title, but there was no substantive company-specific discussion.

Discussed alongside Schrödinger, Inc. (SDGR)

Other assets that creators frequently mention in the same content as Schrödinger, Inc..

Frequently asked

Are top creators bullish or bearish on Schrödinger, Inc. (SDGR) right now?

Mostly bearish. In the last 30 days, 0 insights were bullish, 2 bearish, and 1 neutral about Schrödinger, Inc. (SDGR) across 3 financial sources indexed on Kazuha.

Which podcasters and creators cover Schrödinger, Inc. (SDGR) the most?

The most active sources covering Schrödinger, Inc. (SDGR) on Kazuha are @realmartinshkreli, @theshkrelipill, @aaronrosspreipo. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Schrödinger, Inc. (SDGR) are on Kazuha?

Kazuha has indexed 5 AI-extracted insights about Schrödinger, Inc. (SDGR) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Schrödinger, Inc. (SDGR)?

Creators covering Schrödinger, Inc. (SDGR) most frequently also discuss GOOGL, AMD, NVDA, MRNA, SLS. See the "Discussed alongside" section above for full asset pages.